SCHEMBL31312465

SCHEMBL31312465

[2H]C(O)c1cccc(Br)c1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31088397 0.86 — —
SCHEMBL31088403 0.86 — —
SCHEMBL93041 0.81 — —
SCHEMBL31589213 0.79 — —
SCHEMBL643177 0.77 TAAR1 (0.63) —
SCHEMBL31588815 0.77 — —
Ethylene SCHEMBL27825961 0.77 TAAR1 (0.52) —
SCHEMBL4399626 0.75 TAAR1 (0.74) —
SCHEMBL9200966 0.75 TAAR1 (0.60) —
SCHEMBL81535 0.74 TAAR1 (0.59) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024263563-A1 METABOTROPIC GLUTAMATE SUBTYPE-2 AND -3 RECEPTOR POSITIVE ALLOSTERIC MODULATORS AND USES THEREOF Sanford Burnham Prebys Medical Discovery Institute (US) 2024-12-26 — — WO disclosed
Send feedback